Research and Development

The Research and Development team at Rigel Pharmaceuticals is dedicated to the discovery and advancement of innovative small-molecule therapies targeting immune diseases and cancers. This multidisciplinary group collaborates on drug design, preclinical and clinical research, regulatory affairs, and medical communications, working to translate scientific discoveries into impactful treatments that improve patient outcomes.